Developer docs
API playgroundTry for free, no card

Search company profiles

Apexus

Full company profile

uuid000anuw

Namestring
Apexus
Legal namestring
Apexus, LLC
Websiteurl
340bpvp.com
Company typeenum
Private
Founded yearint
2007
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersIrving, United States
HQ citystring
Irving
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
340B drug pricing, pharmaceutical distribution, healthcare compliance, prime vendor services, drug pricing program
Industry2 codes
PRIMARYHLAFALAL
340B Program Administration & Contract Pharmacy Services
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
SECONDARYHLAIAKAE
Government Pricing & Compliance (Medicare/Medicaid/340B/AMP/Best Price)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing
NAICS code1 code
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
SIC code1 code
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Pharmaceutical Contract Administration
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1HRSA Prime Vendor Contract
TypeManaged Services
Description

Apexus serves as the HRSA-contracted Prime Vendor for the 340B Drug Pricing Program under a competitively awarded government contract. The program is voluntary for covered entities and manufacturers. No enrollment fee is charged to eligible covered entities. Revenue is generated through the administrative and service fees associated with the HRSA contract, manufacturer pricing negotiations, and value-added services.

340bpvp.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others
Pricing details1 tier
1Free enrollment for all eligible 340B covered entities
ModelSubscriptionBilling cadenceAnnual
Notes

The 340B Prime Vendor Program has no enrollment fee. Eligible covered entities (safety-net hospitals, clinics, grantees) can enroll at no cost and receive access to sub-340B pricing, the secure participant website, purchasing analytics, education resources, and the Apexus Answers call center.

340bpvp.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 4 records shown
1Apexus Answers
Description

A national call center providing 340B information support, recognized by 2024 Stevie Awards for customer satisfaction

340bpvp.com
+3 more records
Core offering1 text field

Apexus operates as the HRSA-contracted Prime Vendor for the 340B Drug Pricing Program, negotiating sub-ceiling drug pricing with manufacturers, setting distribution standards across a network of wholesalers and specialty distributors, and delivering education, compliance tools, and technical assistance to safety-net hospitals, government grantee clinics, and other 340B covered entities across the United States. Program participation is free for eligible covered entities, and Apexus also administers the Manufacturer Refund Service, vaccine pricing programs, and the 340B University training and certification programs.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Over $486 million in manufacturer refunds returned to covered entities since inception
+2 more records
Product overview1 text field

Apexus operates the 340B Prime Vendor Program (PVP), a comprehensive platform for managing the federal 340B Drug Pricing Program under contract with HRSA. The core offering includes negotiated manufacturer discounts, a distribution network, and compliance support. The product portfolio comprises the core PVP platform, supplemented by education services (340B University), technical support (Apexus Answers), the Manufacturer Refund Service, vaccine pricing programs, compliance tools (340B Tools), and state-specific Medicaid profiles. Additional offerings include the Advanced 340B Operations Certificate Program for professional certification and the Covered Entity Refund Service.

Product and service7 records
1340B Prime Vendor Program (PVP)
CategoryPrime Vendor / Healthcare Contract Administration
2Apexus Answers
CategoryTechnical Support / Customer Service
3340B University
CategoryEducation and Training
4Manufacturer Refund Service
CategoryRefund / Reconciliation Service
5Advanced 340B Operations Certificate Program (340B ACEs)
CategoryProfessional Certification
6PVP Vaccine Program
CategoryPharmaceutical Pricing Program
7340B Medicaid Profiles
CategoryReference Database
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
1Hercules Pharmaceuticals
Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-12-08
Description

Hercules Pharmaceuticals was approved as an authorized distributor in the Apexus 340B Prime Vendor Program in December 2025. This approval expands the distribution network available to PVP participants for accessing 340B drug products through authorized channels.

businesswire.com
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Apexus partners with the 340B Coalition to deliver 340B University programming at the annual 340B Coalition Summer Conference in National Harbor, MD (July 12-15, 2026). The Coalition serves as a key channel for reaching covered entities and delivering education on 340B compliance and program management.

3ASHP (American Society of Health-System Pharmacists)
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Apexus delivers 340B University at ASHP Leaders Conference (October 2026, Rosemont, IL) and ASHP Midyear Clinical Meeting (December 2026, Orlando, FL). ASHP is a key professional organization for pharmacists and serves as a major distribution channel for 340B education to pharmacy leaders and buyers.

340bpvp.com
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Apexus delivers 340B University at the NPPA Annual Conference (August 17-20, 2026, Las Vegas, NV). NPPA serves pharmacy purchasing professionals who are key decision-makers for 340B program participation and purchasing strategy.

5HRSA (Health Resources and Services Administration)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Apexus serves as the Prime Vendor under a contract awarded by HRSA, the federal agency responsible for administering the 340B Drug Pricing Program. HRSA contracts with the prime vendor to provide education, technical assistance, and manufacturer pricing negotiations for all 340B stakeholders. Apexus was selected to continue as the HRSA 340B Prime Vendor following a competitive, open bid process.

340bpvp.com
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Apexus participates in the Informa Medicaid Drug Rebate Program Summit (November 2-5, 2026, Chicago, IL), a major industry event addressing pharmaceutical pricing and rebate programs relevant to 340B stakeholders.

7Becker's Healthcare
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Apexus participates in Becker's Annual CEO + CFO Roundtable and Becker's Fall Chief Pharmacy Officer Summit, major healthcare executive conferences covering hospital operations, finance, and pharmacy strategy relevant to 340B program decisions.

340bpvp.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Acquired by Cencora (formerly AmerisourceBergen), Sentry Data Systems provides 340B program management software and split-billing solutions to hospitals and pharmacies. It is the closest comparable to Apexus on the software-enabled 340B administration side, though Apexus holds the unique Prime Vendor contract.

TypeDirect peer
Description

Provides 340B software, split-billing, and contract pharmacy management to covered entities. Competes with Apexus-affiliated tools in the same hospital pharmacy 340B market and serves overlapping covered-entity customers.

TypeDirect peer
Description

A 340B solutions provider specializing in contract pharmacy management and reverse-distribution services. Operates in the same 340B TPA/tech ecosystem that complements or substitutes for parts of Apexus's Prime Vendor program.

TypeDirect peer
Description

340B compliance and split-billing software vendor serving health systems, FQHCs, and contract pharmacies. Comparable to Apexus in the 340B software-administration category, particularly for grantee and hospital covered entities.

TypeDirect peer
Description

340B consulting and program administration firm supporting hospitals, FQHCs, and Ryan White grantees. Comparable in the 340B services and audit/compliance space where Apexus also competes via 340B Tools and Apexus Answers.

TypeDirect peer
Description

Specialized pharmacy and 340B consulting firm serving hospitals and health systems. Operates in the same 340B advisory ecosystem that complements Apexus's contract catalog and compliance offerings.

TypeEmerging player
Description

340B management platform vendor focused on contract pharmacy programs and covered-entity software. A smaller, emerging 340B software participant competing for similar covered-entity relationships.

TypeBroad incumbent
Description

One of the Big Three US pharmaceutical wholesalers and owner of Sentry Data Systems. Operates as an authorized distributor in Apexus's PVP network while also competing indirectly via its own 340B software and services portfolio.

TypeBroad incumbent
Description

Major US pharmaceutical wholesaler that participates in the 340B distribution network under Apexus's PVP standards. Comparable as a broad healthcare distribution incumbent with overlapping 340B drug-flow economics.

10McKesson
TypeBroad incumbent
Description

One of the largest US pharmaceutical wholesalers and authorized 340B distributor. Comparable as a broad healthcare supply-chain incumbent that channels significant 340B drug volume through Apexus's PVP framework.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Apexus

Pharmaceutical Contract Administration340bpvp.com

Apexus firmographics

Firmographics
Name
Apexus
Legal name
Apexus, LLC
Website
https://340bpvp.com
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
101–250 employees
Ownership category
akta.pro rank

Apexus industry classification

Industry
Product category
Pharmaceutical Contract Administration
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (42421)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAFALAL
340B Program Administration & Contract Pharmacy Services
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
SECONDARYHLAIAKAE
Government Pricing & Compliance (Medicare/Medicaid/340B/AMP/Best Price)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing

Keywords

  • 340B drug pricing
  • Pharmaceutical distribution
  • Healthcare compliance
  • Prime vendor services
  • Drug pricing program

Where Apexus is headquartered

Location

Headquarters

HQ city
Irving
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Apexus business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others

Revenue model

  1. HRSA Prime Vendor Contract: Apexus serves as the HRSA-contracted Prime Vendor for the 340B Drug Pricing Program under a competitively awarded government contract. The program is voluntary for covered entities and manufacturers. No enrollment fee is charged to eligible covered entities. Revenue is generated through the administrative and service fees associated with the HRSA contract, manufacturer pricing negotiations, and value-added services.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualFree enrollment for all eligible 340B covered entities

Go-to-market motion2 records

Distribution channels4 records

Marketing channels9 records

Apexus product offering

Product offering

Core offering

Apexus operates as the HRSA-contracted Prime Vendor for the 340B Drug Pricing Program, negotiating sub-ceiling drug pricing with manufacturers, setting distribution standards across a network of wholesalers and specialty distributors, and delivering education, compliance tools, and technical assistance to safety-net hospitals, government grantee clinics, and other 340B covered entities across the United States. Program participation is free for eligible covered entities, and Apexus also administers the Manufacturer Refund Service, vaccine pricing programs, and the 340B University training and certification programs.

Product overview

Apexus operates the 340B Prime Vendor Program (PVP), a comprehensive platform for managing the federal 340B Drug Pricing Program under contract with HRSA. The core offering includes negotiated manufacturer discounts, a distribution network, and compliance support. The product portfolio comprises the core PVP platform, supplemented by education services (340B University), technical support (Apexus Answers), the Manufacturer Refund Service, vaccine pricing programs, compliance tools (340B Tools), and state-specific Medicaid profiles. Additional offerings include the Advanced 340B Operations Certificate Program for professional certification and the Covered Entity Refund Service.

Differentiator

Problem solved

Functional benefit

Brands

  • Apexus Answers: A national call center providing 340B information support, recognized by 2024 Stevie Awards for customer satisfaction
  • 340B University
  • 340B ACEs (Apexus Certified Experts)
  • Covered Entity Refund Service

Products and services

  • 340B Prime Vendor Program (PVP)
  • Apexus Answers
  • 340B University
  • Manufacturer Refund Service
  • Advanced 340B Operations Certificate Program (340B ACEs)
  • PVP Vaccine Program
  • 340B Medicaid Profiles

Quantifiable outcome

  • Over $486 million in manufacturer refunds returned to covered entities since inception
  • +2 more outcomes

Companies that use Apexus

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles4 records

Apexus technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Apexus partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered minor and core.

  • Hercules PharmaceuticalsminorChannel Partner/ Reseller/ Distributor · 8 December 2025Hercules Pharmaceuticals was approved as an authorized distributor in the Apexus 340B Prime Vendor Program in December 2025. This approval expands the distribution network available to PVP participants for accessing 340B drug products through authorized channels.
  • 340B CoalitioncoreChannel Partner/ Reseller/ DistributorApexus partners with the 340B Coalition to deliver 340B University programming at the annual 340B Coalition Summer Conference in National Harbor, MD (July 12-15, 2026). The Coalition serves as a key channel for reaching covered entities and delivering education on 340B compliance and program management.
  • ASHP (American Society of Health-System Pharmacists)coreChannel Partner/ Reseller/ DistributorApexus delivers 340B University at ASHP Leaders Conference (October 2026, Rosemont, IL) and ASHP Midyear Clinical Meeting (December 2026, Orlando, FL). ASHP is a key professional organization for pharmacists and serves as a major distribution channel for 340B education to pharmacy leaders and buyers.
  • NPPA (National Pharmacy Purchasing Association)minorChannel Partner/ Reseller/ DistributorApexus delivers 340B University at the NPPA Annual Conference (August 17-20, 2026, Las Vegas, NV). NPPA serves pharmacy purchasing professionals who are key decision-makers for 340B program participation and purchasing strategy.
  • HRSA (Health Resources and Services Administration)coreStrategic or Co-development PartnerApexus serves as the Prime Vendor under a contract awarded by HRSA, the federal agency responsible for administering the 340B Drug Pricing Program. HRSA contracts with the prime vendor to provide education, technical assistance, and manufacturer pricing negotiations for all 340B stakeholders. Apexus was selected to continue as the HRSA 340B Prime Vendor following a competitive, open bid process.
  • Informa (Medicaid Drug Rebate Program Summit)minorChannel Partner/ Reseller/ DistributorApexus participates in the Informa Medicaid Drug Rebate Program Summit (November 2-5, 2026, Chicago, IL), a major industry event addressing pharmaceutical pricing and rebate programs relevant to 340B stakeholders.
  • Becker's HealthcareminorChannel Partner/ Reseller/ DistributorApexus participates in Becker's Annual CEO + CFO Roundtable and Becker's Fall Chief Pharmacy Officer Summit, major healthcare executive conferences covering hospital operations, finance, and pharmacy strategy relevant to 340B program decisions.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Apexus competitors and assessment

Company assessment

Direct peers

  • Sentry Data Systems: Acquired by Cencora (formerly AmerisourceBergen), Sentry Data Systems provides 340B program management software and split-billing solutions to hospitals and pharmacies. It is the closest comparable to Apexus on the software-enabled 340B administration side, though Apexus holds the unique Prime Vendor contract.
  • Macro Helix: Provides 340B software, split-billing, and contract pharmacy management to covered entities. Competes with Apexus-affiliated tools in the same hospital pharmacy 340B market and serves overlapping covered-entity customers.
  • CaptureRx: A 340B solutions provider specializing in contract pharmacy management and reverse-distribution services. Operates in the same 340B TPA/tech ecosystem that complements or substitutes for parts of Apexus's Prime Vendor program.
  • Verity Solutions: 340B compliance and split-billing software vendor serving health systems, FQHCs, and contract pharmacies. Comparable to Apexus in the 340B software-administration category, particularly for grantee and hospital covered entities.
  • BHM Healthcare Solutions: 340B consulting and program administration firm supporting hospitals, FQHCs, and Ryan White grantees. Comparable in the 340B services and audit/compliance space where Apexus also competes via 340B Tools and Apexus Answers.
  • Visante: Specialized pharmacy and 340B consulting firm serving hospitals and health systems. Operates in the same 340B advisory ecosystem that complements Apexus's contract catalog and compliance offerings.

Emerging players

  • SunRx: 340B management platform vendor focused on contract pharmacy programs and covered-entity software. A smaller, emerging 340B software participant competing for similar covered-entity relationships.

Broad incumbents

  • Cencora (AmerisourceBergen): One of the Big Three US pharmaceutical wholesalers and owner of Sentry Data Systems. Operates as an authorized distributor in Apexus's PVP network while also competing indirectly via its own 340B software and services portfolio.
  • Cardinal Health: Major US pharmaceutical wholesaler that participates in the 340B distribution network under Apexus's PVP standards. Comparable as a broad healthcare distribution incumbent with overlapping 340B drug-flow economics.
  • McKesson: One of the largest US pharmaceutical wholesalers and authorized 340B distributor. Comparable as a broad healthcare supply-chain incumbent that channels significant 340B drug volume through Apexus's PVP framework.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Apexus social profiles

Digital presence

Apexus financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Apexus leadership team

Management profile

Number of profiles

Profiles1 record

Apexus funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Apexus M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Apexus

What does Apexus do?

Apexus operates as the HRSA-contracted Prime Vendor for the 340B Drug Pricing Program, negotiating sub-ceiling drug pricing with manufacturers, setting distribution standards across a network of wholesalers and specialty distributors, and delivering education, compliance tools, and technical assistance to safety-net hospitals, government grantee clinics, and other 340B covered entities across the United States. Program participation is free for eligible covered entities, and Apexus also administers the Manufacturer Refund Service, vaccine pricing programs, and the 340B University training and certification programs.

Is Apexus a public or private company?

Apexus is a private company. It is classified as corporate owned and is currently operating.

When was Apexus founded?

Apexus was founded in 2007. It employs 101 to 250 people.

Where is Apexus based?

Apexus is headquartered in Irving, United States, in the North America region.

How does Apexus make money?

One revenue line is on record: HRSA Prime Vendor Contract.

Who are Apexus's main competitors?

Direct peers on record are Sentry Data Systems, Macro Helix, CaptureRx, Verity Solutions, BHM Healthcare Solutions and Visante. SunRx is listed as an emerging player. Broad incumbents are Cencora (AmerisourceBergen), Cardinal Health and McKesson.

Does Apexus have an API?

No public API is recorded for Apexus.

What industry is Apexus in?

Apexus's product category is Pharmaceutical Contract Administration. Its primary akta.pro industry code is HLAFALAL, 340B Program Administration & Contract Pharmacy Services, with a secondary code of HLAIAKAE, Government Pricing & Compliance (Medicare/Medicaid/340B/AMP/Best Price). Its NAICS code is 42421 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FierceHealthcareTrump administration restarts its efforts to pilot 340B rebatesThe Trump administration, through the Health Resources and Services Administration (HRSA), has released a request for information (RFI) seeking public input on implementing a rebate model for the 340B Drug Discount Program, restarting efforts just a week after a previous pilot was blocked by a court. The RFI, which has a March 19 deadline, asks stakeholders for input on cash-flow impacts, whether hospitals' reliance on upfront discounts is reasonable, and what safeguards should be implemented. Senator Bruce Cassidy has also escalated scrutiny by sending an information request to Apexus—the 340B Program's prime vendor—requesting details on its revenues and business practices.The New York TimesSenate Questions Health Care Firm for Profiting Off Program Meant for PoorThe Senate Health Committee is investigating Apexus, a Texas-based company, over its profits and practices related to the 340B Drug Price Program. The program, originally intended to help safety-net hospitals, now covers over half of US nonprofit hospitals, raising concerns about rising healthcare costs. The committee sent a letter to Apexus questioning its role and profit model.MorningstarAHF: Drain the Apexus SwampAIDS Healthcare Foundation (AHF) has called on the Department of Health and Human Services to immediately void Apexus's contract to manage the 340B Drug Pricing Program, alleging the federal contractor has conflicts of interest that prioritize profits for its parent company Vizient over discounted drug pricing for eligible healthcare providers. AHF filed suit against Apexus in 2022 alleging the prime vendor failed to negotiate in good faith for sub-ceiling price discounts on HIV therapeutics, instead directing resources toward drugs used by larger 340B hospital clients. Senator Bill Cassidy (R-LA) has opened a congressional inquiry into Apexus following a 2025 New York Times exposé documenting how the entity "supercharges" the 340B program to generate fees for every drug sold.YahooHarrow Enters into 340B Prime Vendor Program Contract with Apexus™ for IHEEZO® and Other Key Harrow ProductsHarrow announced on July 9, 2024 that it entered an agreement with Apexus to make IHEEZO and other products available through the 340B Prime Vendor Program as of July 1, 2024. The program, managed by Apexus, is awarded by HRSA and includes about 44% of U.S. hospitals. The agreement aims to open access to IHEEZO for the U.S. hospital market.PR NewswireHeron Therapeutics Announces 340B Prime Vendor Contract with Apexus for ZYNRELEF™Heron Therapeutics announced it has executed a 340B Prime Vendor contract with Apexus, LLC to make ZYNRELEF available at discounted pricing to participating covered entities serving vulnerable communities. ZYNRELEF, approved by the FDA in May 2021, is the first and only extended-release dual-acting local anesthetic designed to manage postoperative pain for up to 72 hours and reduce or eliminate opioid use following surgery. The partnership aims to increase access to this non-opioid pain management option as part of broader efforts to address the U.S. opioid epidemic.PR NewswireMedunik USA expands access to Siklos® for pediatric sickle cell anemia patients by offering 340B pricing to covered entities through ApexusMedunik USA announced on April 9, 2019, that Siklos®, the first and only FDA-approved hydroxyurea-based treatment for pediatric sickle cell anemia patients, is now available through the 340B Pricing Program Prime Vendor (Apexus) at discounted pricing to expand access. The company is offering Sub-WAC pricing for patients not eligible for 340B product dispensing, including disproportionate share hospitals, children's hospitals, and freestanding cancer clinics. Siklos® is indicated to reduce the frequency of painful crises and the need for blood transfusions in children two years and older with recurrent moderate to severe painful crises.PR NewswireARKRAY USA Selected as Apexus 340B Prime Vendor Program Supplier for Blood Glucose Monitoring SystemsARKRAY USA has been selected as a contracted supplier for the 340B Prime Vendor Program managed by Apexus, providing blood glucose monitoring systems to qualifying healthcare facilities. The company will supply specific devices such as the GLUCOCARD® Expression™ and GLUCOCARD® Shine to help patients manage diabetes at discounted rates.